Terms: = Leukemia AND CALCB, Calcitonin
116 results:
1. CALCRL knockdown suppresses cancer stemness and chemoresistance in acute myeloid leukemia with FLT3-ITD and DNM3TA-R882 double mutations.
Tang S; Zhu H; Sheng L; Mu Q; Wang Y; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Drug Dev Res; 2024 Feb; 85(1):e22137. PubMed ID: 38349260
[TBL] [Abstract] [Full Text] [Related]
2. CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway.
Tang S; Li S; Shi X; Sheng L; Mu Q; Wang Y; Zhu H; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Anticancer Drugs; 2024 Feb; 35(2):163-176. PubMed ID: 37948318
[TBL] [Abstract] [Full Text] [Related]
3. The CGRP Receptor Antagonist MK0974 Induces EVI1
Suekane A; Ichikawa T; Saito Y; Nakahata S; Morishita K
Anticancer Res; 2022 Oct; 42(10):4743-4752. PubMed ID: 36191988
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of CALCRL-associated prognostic genes in acute myeloid leukemia.
Huang Z; Zhang H; Xing C; Zhang L; Zhu H; Deng Z; Yin L; Dong E; Wang C; Peng H
Gene; 2022 Jan; 809():146009. PubMed ID: 34655717
[TBL] [Abstract] [Full Text] [Related]
5. calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML.
Angenendt L; Wöste M; Mikesch JH; Arteaga MF; Angenendt A; Sandmann S; Berdel WE; Lenz G; Dugas M; Meshinchi S; Schliemann C; Rössig C
Blood Adv; 2021 Nov; 5(21):4413-4421. PubMed ID: 34559198
[TBL] [Abstract] [Full Text] [Related]
6. Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
Shacham EC; Marshak DC; Brikman S; Dori G; Ishay A
Medicine (Baltimore); 2021 Apr; 100(14):e24982. PubMed ID: 33832072
[TBL] [Abstract] [Full Text] [Related]
7. Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.
Larrue C; Guiraud N; Mouchel PL; Dubois M; Farge T; Gotanègre M; Bosc C; Saland E; Nicolau-Travers ML; Sabatier M; Serhan N; Sahal A; Boet E; Mouche S; Heydt Q; Aroua N; Stuani L; Kaoma T; Angenendt L; Mikesch JH; Schliemann C; Vergez F; Tamburini J; Récher C; Sarry JE
Nat Commun; 2021 Jan; 12(1):422. PubMed ID: 33462236
[TBL] [Abstract] [Full Text] [Related]
8. The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.
Angenendt L; Bormann E; Pabst C; Alla V; Görlich D; Braun L; Dohlich K; Schwöppe C; Bohlander SK; Arteaga MF; Wethmar K; Hartmann W; Angenendt A; Kessler T; Mesters RM; Stelljes M; Rothenberg-Thurley M; Spiekermann K; Hébert J; Sauvageau G; Valk PJM; Löwenberg B; Serve H; Müller-Tidow C; Lenz G; Wörmann BJ; Sauerland MC; Hiddemann W; Berdel WE; Krug U; Metzeler KH; Mikesch JH; Herold T; Schliemann C
Leukemia; 2019 Dec; 33(12):2830-2841. PubMed ID: 31182782
[TBL] [Abstract] [Full Text] [Related]
9. Acute Lymphoblastic leukemia with Malignant Hypercalcemia: A Case Report.
Bota M; Popa G; Neaga A; Gocan H; Blag CL
Am J Case Rep; 2019 Mar; 20():402-405. PubMed ID: 30918242
[TBL] [Abstract] [Full Text] [Related]
10. Severe hypercalcemia: A rare and unusual presentation of acute lymphoblastic leukemia.
Dhivyasree S; Dhivyalakshmi J; Sankaranarayanan S; Scott JX
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1244-S1246. PubMed ID: 30539882
[TBL] [Abstract] [Full Text] [Related]
11. Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.
Rujirachun P; Junyavoraluk A; Owattanapanich W; Suvannarerg V; Sirinvaravong S
J Med Case Rep; 2018 Sep; 12(1):257. PubMed ID: 30196795
[TBL] [Abstract] [Full Text] [Related]
12. [Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
Gao HH; Yao ZL; Li Y; Huang S; Liu J; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):684-690. PubMed ID: 29950204
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients.
Russell L; Madsen MB; Dahl M; Kampmann P; Perner A
Acta Anaesthesiol Scand; 2018 Feb; 62(2):196-206. PubMed ID: 29124749
[TBL] [Abstract] [Full Text] [Related]
14. Chronic Myeloid leukemia Associated Hypercalcemia: A Case Report and Literature Review.
Toro-Tobón D; Agosto S; Ahmadi S; Koops M; Bruder JM
Am J Case Rep; 2017 Feb; 18():203-207. PubMed ID: 28239141
[TBL] [Abstract] [Full Text] [Related]
15. Severe Hypercalcemia in a Child With Acute Lymphoblastic leukemia Relapse: Successful Management With Combination of calcitonin and Bisphosphonate.
Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
[TBL] [Abstract] [Full Text] [Related]
16. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract] [Full Text] [Related]
17. Administration of calcitonin promotes blastocyst implantation in mice by up-regulating integrin β3 expression in endometrial epithelial cells.
Xiong T; Zhao Y; Hu D; Meng J; Wang R; Yang X; Ai J; Qian K; Zhang H
Hum Reprod; 2012 Dec; 27(12):3540-51. PubMed ID: 23001774
[TBL] [Abstract] [Full Text] [Related]
18. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.
Khoury N; Chang J; Gru AA; Whyte MP
J Clin Endocrinol Metab; 2012 Sep; 97(9):3051-5. PubMed ID: 22730513
[TBL] [Abstract] [Full Text] [Related]
19. High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples.
Leach RE; Jessmon P; Coutifaris C; Kruger M; Myers ER; Ali-Fehmi R; Carson SA; Legro RS; Schlaff WD; Carr BR; Steinkampf MP; Silva S; Leppert PC; Giudice L; Diamond MP; Armant DR;
Hum Reprod; 2012 Mar; 27(3):814-28. PubMed ID: 22215622
[TBL] [Abstract] [Full Text] [Related]
20. Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).
Gosney JR; Williams IJ; Dodson AR; Foster CS
Histopathology; 2011 Oct; 59(4):751-62. PubMed ID: 22014055
[TBL] [Abstract] [Full Text] [Related]
[Next]
